NCT01396837View on ClinicalTrials.gov

Safety Trial of the RedDress Wound Care System (RD1) in Management of Texas 1a or 2a Neuropathic Diabetic Foot Ulcers.

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

March 31, 2017

Conditions
Neuropathic Diabetic Ulcer - Foot
Interventions
DEVICE

RedDress Wound Care System (RD1)

Weekly application. A blood based wound care treatment

Trial Locations (4)

15222

SerenaGroup Research Institute, Pittsburgh

17402

Martin Foot and Ankle, York

33169

Barry University Clinical Research, North Miami Beach

33185

Amun Research, Miami

All Listed Sponsors
lead

RedDress Ltd.

INDUSTRY

NCT01396837 - Safety Trial of the RedDress Wound Care System (RD1) in Management of Texas 1a or 2a Neuropathic Diabetic Foot Ulcers. | Biotech Hunter | Biotech Hunter